Curative Biosciences, Inc. (CBDX) Financial Statements (2026 and earlier)

Company Profile

Business Address 5042 WILSHIRE BLVD.
LOS ANGELES, CA 90036
State of Incorp. NV
Fiscal Year End June 30
Industry (SIC) 209 - Miscellaneous Food Preparations And Kindred (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2018
MRQ
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments   222
Cash and cash equivalent   222
Prepaid expense    2✕
Other undisclosed current assets     62
Total current assets:   2464
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization 25811 
Intangible asset, including goodwill, after accumulated amortization   (174)3✕
Intangible asset, excluding goodwill, after accumulated amortization   (174)3 
Other undisclosed noncurrent assets   174(3)55
Total noncurrent assets: 2581155
Other undisclosed assets    1 
TOTAL ASSETS: 251016119
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 18835331692105
Taxes payable  18218200
Employee-related liabilities 4444 
Accounts payable 17716112389105
Accrued liabilities 777  
Debt 6350   
Estimated litigation liability 201201   
Due to related parties   9  
Other undisclosed current liabilities 18217381157566
Total current liabilities: 633620706249671
Noncurrent Liabilities
Total liabilities: 633620706249671
Equity
Equity, attributable to parent, including: (631)(615)(696)(234)(552)
Common stock 1616115 
Additional paid in capital 52,51652,47950,74547,79217,516
Accumulated deficit (53,162)(53,109)(51,452)(18,085) 
Other undisclosed equity, attributable to parent    (29,946)(18,067)
Total equity: (631)(615)(696)(234)(552)
TOTAL LIABILITIES AND EQUITY: 251016119

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2018
TTM
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues    161162
Revenue, net    161 
Cost of revenue     (106)
Gross profit:    16156
Operating expenses (53)(1,657)3,369(29,946)(895)
Other undisclosed operating loss    (161) 
Operating income (loss): (53)(1,657)3,369(29,946)(838)
Income (loss) from continuing operations: (53)(1,657)3,369(29,946)(838)
Income (loss) before gain (loss) on sale of properties: (53)(1,657)3,369(29,946)(838)
Other undisclosed net loss   (6,737)  
Net loss: (53)(1,657)(3,369)(29,946)(838)
Other undisclosed net loss attributable to parent     (5,800)
Net loss available to common stockholders, diluted: (53)(1,657)(3,369)(29,946)(6,638)

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2018
TTM
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net loss: (53)(1,657)(3,369)(29,946)(838)
Comprehensive loss, net of tax, attributable to parent: (53)(1,657)(3,369)(29,946)(838)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: